T. Rowe Price Associates’s Aetna Inc AET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,959,258
Closed -$600M 2630
2018
Q3
$600M Sell
2,959,258
-3,990,867
-57% -$780M 0.09% 235
2018
Q2
$1.28B Sell
6,950,125
-1,523,854
-18% -$272M 0.19% 119
2018
Q1
$1.43B Sell
8,473,979
-8,037,589
-49% -$1.44B 0.23% 100
2017
Q4
$2.98B Sell
16,511,568
-4,801,669
-23% -$825M 0.48% 37
2017
Q3
$3.39B Sell
21,313,237
-283,924
-1% -$44.4M 0.58% 28
2017
Q2
$3.28B Buy
21,597,161
+223,488
+1% +$31.6M 0.59% 26
2017
Q1
$2.73B Sell
21,373,673
-7,085,290
-25% -$890M 0.51% 34
2016
Q4
$3.53B Sell
28,458,963
-4,247,118
-13% -$508M 0.7% 19
2016
Q3
$3.78B Buy
32,706,081
+267,743
+0.8% +$31.4M 0.76% 17
2016
Q2
$3.96B Buy
32,438,338
+3,108,173
+11% +$357M 0.84% 16
2016
Q1
$3.3B Buy
29,330,165
+10,120,164
+53% +$1.08B 0.7% 26
2015
Q4
$2.08B Buy
19,210,001
+2,385,631
+14% +$258M 0.44% 46
2015
Q3
$1.84B Buy
16,824,370
+6,834,722
+68% +$790M 0.41% 52
2015
Q2
$1.27B Buy
9,989,648
+630,725
+7% +$72M 0.26% 87
2015
Q1
$997M Buy
9,358,923
+159,470
+2% +$15.6M 0.21% 121
2014
Q4
$817M Buy
9,199,453
+1,792,333
+24% +$150M 0.17% 150
2014
Q3
$600M Buy
7,407,120
+411,347
+6% +$33.5M 0.13% 185
2014
Q2
$567M Sell
6,995,773
-488,600
-7% -$37M 0.12% 201
2014
Q1
$561M Buy
7,484,373
+1,692,714
+29% +$120M 0.13% 203
2013
Q4
$397M Sell
5,791,659
-801,100
-12% -$52.3M 0.09% 263
2013
Q3
$422M Buy
6,592,759
+345,981
+6% +$22.2M 0.11% 237
2013
Q2
$397M Buy
+6,246,778
New +$367M 0.11% 240

Other funds holding AET

T. Rowe Price Associates's AET Position: Q4 2018 in Review

T. Rowe Price Associates sold out of Aetna Inc (AET) in Q4 2018, closing a stake of 2,959,258 shares — an estimated $600M sold.

T. Rowe Price Associates first reported a position in AET in Q2 2013 and held it in 22 quarters. The position peaked at $3.96B in Q2 2016. 6 funds tracked by Wall St. Rank hold AET as of Q4 2018.

  • T. Rowe Price Associates reported no remaining Aetna Inc position as of Q4 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,959,258 Aetna Inc shares in Q4 2018, an estimated $600M.
  • T. Rowe Price Associates first reported a position in Aetna Inc in Q2 2013 and held it in 22 quarters.
  • T. Rowe Price Associates's Aetna Inc position peaked at $3.96B in Q2 2016.
  • 6 funds tracked by Wall St. Rank held Aetna Inc as of Q4 2018.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.